104 related articles for article (PubMed ID: 26068011)
1. Geographical Distribution of Myasthenia Gravis in Northern Europe--Results from a Population-Based Study from Two Countries.
Boldingh MI; Maniaol AH; Brunborg C; Dekker L; Heldal AT; Lipka AF; Popperud TH; Niks EH; Verschuuren JJ; Tallaksen CM
Neuroepidemiology; 2015; 44(4):221-31. PubMed ID: 26068011
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece.
Tsiamalos P; Kordas G; Kokla A; Poulas K; Tzartos SJ
Eur J Neurol; 2009 Aug; 16(8):925-30. PubMed ID: 19374661
[TBL] [Abstract][Full Text] [Related]
3. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical aspects of immigrants with myasthenia gravis in northern Europe.
Boldingh MI; Maniaol A; Brunborg C; Dekker L; Lipka A; Niks EH; Verschuuren J; Tallaksen C
Muscle Nerve; 2017 Jun; 55(6):819-827. PubMed ID: 27641227
[TBL] [Abstract][Full Text] [Related]
6. Different characteristic phenotypes according to antibody in myasthenia gravis.
Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384
[TBL] [Abstract][Full Text] [Related]
7. A nationwide epidemiological study of myasthenia gravis in Latvia.
Zieda A; Ravina K; Glazere I; Pelcere L; Naudina MS; Liepina L; Kamsa I; Kurjane N; Woodhall M; Jacobson L; Leite MI; Tandon K; Kenina V
Eur J Neurol; 2018 Mar; 25(3):519-526. PubMed ID: 29194859
[TBL] [Abstract][Full Text] [Related]
8. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries.
Andersen JB; Heldal AT; Engeland A; Gilhus NE
Acta Neurol Scand Suppl; 2014; (198):26-31. PubMed ID: 24588503
[TBL] [Abstract][Full Text] [Related]
9. Complete stable remission and autoantibody specificity in myasthenia gravis.
Baggi F; Andreetta F; Maggi L; Confalonieri P; Morandi L; Salerno F; Bernasconi P; Montomoli C; Barberis M; Mantegazza R; Antozzi C
Neurology; 2013 Jan; 80(2):188-95. PubMed ID: 23255823
[TBL] [Abstract][Full Text] [Related]
10. Geographical distribution of a seropositive myasthenia gravis population.
Heldal AT; Eide GE; Gilhus NE; Romi F
Muscle Nerve; 2012 Jun; 45(6):815-9. PubMed ID: 22581533
[TBL] [Abstract][Full Text] [Related]
11. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
[TBL] [Abstract][Full Text] [Related]
12. A national epidemiological study of Myasthenia Gravis in Australia.
Gattellari M; Goumas C; Worthington JM
Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
[TBL] [Abstract][Full Text] [Related]
13. Incidence of seropositive myasthenia gravis in Cape Town and South Africa.
Bateman KJ; Schinkel M; Little F; Liebenberg L; Vincent A; Heckmann JM
S Afr Med J; 2007 Oct; 97(10):959-62. PubMed ID: 18000579
[TBL] [Abstract][Full Text] [Related]
14. Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
Chan KH; Lachance DH; Harper CM; Lennon VA
Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558
[TBL] [Abstract][Full Text] [Related]
15. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological profile of the patients with MuSK positive myasthenia gravis.
Nikolic A; Basta I; Stojanovic VR; Stevic Z; Lavrnic D
Neurol Res; 2014 Nov; 36(11):945-9. PubMed ID: 24825477
[TBL] [Abstract][Full Text] [Related]
17. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
[TBL] [Abstract][Full Text] [Related]
18. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
19. Acquired myasthenia gravis in childhood.
Evoli A
Curr Opin Neurol; 2010 Oct; 23(5):536-40. PubMed ID: 20581680
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
